Close X
Saturday, November 16, 2024
ADVT 
National

Aritzia signs deal to buy Reigning Champ

Darpan News Desk The Canadian Press, 15 Jun, 2021 09:37 AM
  • Aritzia signs deal to buy Reigning Champ

Clothing designer and retailer Aritzia Inc. says it has signed an agreement to buy a Reigning Champ, a designer and manufacturer of premium athletic wear.

Under the agreement, Aritzia will acquire a 75 per cent stake in the company based on an enterprise value of approximately $63 million.

The remaining 25 per cent interest held by Reigning Champ's management shareholders will be converted into Aritzia shares in up to three instalments from 2024 to 2026.

Aritzia chief executive Brian Hill says the deal accelerates the company's expansion into men's clothing.

Reigning Champ's senior leadership team will continue operating the business in partnership with Aritzia through a transition period of approximately five years.

The deal is expected to be completed later this month, subject to customary closing conditions and approvals.

 

MORE National ARTICLES

Opposition parties outline budget priorities

Opposition parties outline budget priorities
NDP Leader Jagmeet Singh has pledged not to trigger an election regardless of what the budget has in store on April 19, a move that potentially weakens New Democrats' say in the final product.

Opposition parties outline budget priorities

Top military police officer defends investigations

Top military police officer defends investigations
Liberal and Bloc MPs shut down a similar study at the Commons defence committee on Monday that was specifically looking into allegations involving former defence chief Gen. Jonathan Vance.

Top military police officer defends investigations

China denies mistreatment of two Michaels

China denies mistreatment of two Michaels
The two Michaels were detained in December 2018 in apparent retaliation for Canada's arrest of Huawei executive Meng Wanzhou on an extradition request from the United States.

China denies mistreatment of two Michaels

How J&J and AstraZeneca differ from mRNA vaccines

How J&J and AstraZeneca differ from mRNA vaccines
It's the second COVID vaccine to be investigated for a possible link to blood clotting after several European countries temporarily halted use of the Oxford-AstraZeneca vaccine for the same reason last month.

How J&J and AstraZeneca differ from mRNA vaccines

Liberals propose right to a healthy environment

Liberals propose right to a healthy environment
The proposed amendment is included in a new bill introduced in the House of Commons today, C-28, which would strengthen The Canadian Environmental Protection Act.

Liberals propose right to a healthy environment

Health Canada investigating J&J blood clot reports

Health Canada investigating J&J blood clot reports
The clots were observed along with reduced platelet counts making the usual treatment for blood clots, the blood thinner heparin, potentially "dangerous.''

Health Canada investigating J&J blood clot reports